Biotricity (NASDAQ:BTCY) Trading Down 1.4% – Time to Sell?

Biotricity, Inc. (NASDAQ:BTCY) dropped 1.4% during trading on Tuesday . The company traded as low as $0.2282 and last traded at $0.2464. Approximately 5,677 shares changed hands during trading, a decline of 89% from the average daily volume of 52,292 shares. The stock had previously closed at $0.2499.

Biotricity Price Performance

The firm’s 50 day moving average price is $0.26 and its two-hundred day moving average price is $0.42. The stock has a market cap of $7.05 million, a PE ratio of -0.23 and a beta of 1.36.

Biotricity (NASDAQ:BTCY) last posted its earnings results on Wednesday, February 11th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.04. The company had revenue of $3.99 million for the quarter. Analysts anticipate that Biotricity, Inc. will post -0.67 earnings per share for the current year.

Biotricity Company Profile

Biotricity, Inc (NASDAQ:BTCY) is a digital health company specializing in remote patient monitoring solutions across cardiovascular and chronic disease management. The firm develops and commercializes a patented wearable biosensor platform designed to capture continuous physiological data, including electrocardiogram (ECG) readings and heart rate variability. This integrated system combines lightweight, adhesive biosensors with cloud-based analytics and clinician-facing software to support early detection of cardiac arrhythmias and facilitate telehealth care delivery.

The company’s flagship offering, the Bioflux™ platform, comprises a small, single-use wearable device that transmits real-time data to a secure portal, where advanced algorithms analyze cardiac patterns and generate clinician alerts.